As of May 18
| +1.65 / +0.94%|
The 23 analysts offering 12-month price forecasts for Amgen Inc have a median target of 192.00, with a high estimate of 224.00 and a low estimate of 165.00. The median estimate represents a +8.91% increase from the last price of 176.30.
The current consensus among 25 polled investment analysts is to Hold stock in Amgen Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.